Polypharmacy: survey of strategies and actions across London

Tell the London RMOC about your approaches to tackling inappropriate polypharmacy. Organisations across London are invited to complete this survey by the 9th February 2018 to inform the work of the London RMOC on this important issue.

1. The name of your organisation *

2. Type of organisation

3. To what extent is polypharmacy considered a priority within your organisation?

Part of the key deliverables
Subsection of one organisational priority
Not specifically mentioned in organisational objectives
Other (please specify):

4. To what extent is polypharmacy a priority across the STP in which your organisation sits?

Part of the key deliverables
Subsection of one organisational priority
Not specifically mentioned in organisational objectives
Other:

Comments on Priorities

5. Which external partners are you engaged with on this work?

6. What is the location of your service?

7. What services in your locality are designed to address prescribing of more medicines than are clinically required (problematic pharmacy)?

Medication review for people on more than a specific number of medicines
Frailty services which include medicines
Medication review for people at higher risk of medication-related problems
Other (please specify):

8. What were the reasons for your specific choice of the type of service?

Previous service evaluation
National/Expert practice guidance
Experience or knowledge of similar service elsewhere
Recognised problem in this locality
Published evidence
Other (please specify):

9. Is your service either specifically commissioned, part of a broader package of MO support, or provided in some other way? Please describe.

10. Is the service spread across a CCG or STP population, or is confined to a particular distinct locality? Please describe.

11. How do you identify your cohort of service users (data, systems)?

12. What tools do you use, if any, to manage people at risk of medicines-related problems as part of medication review?

13. What data categories are being captured?

Harm prevented
Reduction in preventable (potential) medicines-related admissions and readmissions
Reduction in unscheduled preventable medicines-related episodes of care
Clinical interventions
Medicines costs
Medicines started
Medicines stopped
Other (please specify):

14. What impact is being measured?

15. How do you extrapolate impact across your organisation? e.g.

Calculations for costs/impact across organisation
Risk reduction calculation
Other (please specify):

16. What staff resource, and in particular what skill mix, does the service require?

17. Your contact details:
These details will only be used if we need further information from you about this survey. *

Name	*
Role	*
email	*
Telephone	*